Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasms

Human Pathology

Volumn 44, Issue 4, 2013, Pages 542-550

  Mounajjed, Taofic ^a   Zhang, Lizhi ^a   Wu, Tsung Teh ^a  

^a MAYO CLINIC   (United States)

Author keywords

Gastrointestinal tract; Glypican 3; Hepatocellular carcinoma; Pancreas; Pancreatic acinar cell carcinoma

Indexed keywords

GLYPICAN 3;

ACINAR CELL; ADULT; AGED; ANUS CANCER; ARTICLE; BILE DUCT CARCINOMA; CANCER GRADING; CELL DIFFERENTIATION; COLORECTAL CANCER; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; FEMALE; GASTROINTESTINAL CARCINOMA; GASTROINTESTINAL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PANCREAS CARCINOMA; PANCREAS TUMOR; PANCREATIC NEUROENDOCRINE TUMOR; SMALL INTESTINE CANCER; SQUAMOUS CELL CARCINOMA; STAINING; STOMACH CANCER; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SQUAMOUS CELL; CHOLANGIOCARCINOMA; FEMALE; GASTROINTESTINAL NEOPLASMS; GLYPICANS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS;

EID: 84875216403     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.06.016     Document Type: Article

References (60)

1. J. Filmus, and S.B. Selleck Glypicans: proteoglycans with a surprise J Clin Invest 108 2001 497 501
2. P.N. Grozdanov, M.I. Yovchev, and M.D. Dabeva The oncofetal protein glypican-3 is a novel marker of hepatic progenitor/oval cells Lab Invest 86 2006 1272 1284
3. Y. Midorikawa, S. Ishikawa, and H. Iwanari Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling Int J Cancer 103 2003 455 465
4. X.B. Man, L. Tang, and B.H. Zhang Upregulation of Glypican-3 expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancers Liver Int 25 2005 962 966
5. J. Filmus, and M. Capurro The role of glypican-3 in the regulation of body size and cancer Cell Cycle 7 2008 2787 2790
6. M.H. Kwack, B.Y. Choi, and Y.K. Sung Cellular changes resulting from forced expression of glypican-3 in hepatocellular carcinoma cells Mol Cells 21 2006 224 228
7. T. Nakatsura, and Y. Nishimura Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma BioDrugs 19 2005 71 77
8. Z.L. Lu, D.Z. Luo, and J.M. Wen Expression and significance of tumor-related genes in HCC World J Gastroenterol 11 2005 3850 3854
9. B.D. Li, Q.C. Zhao, and Y.T. Zhu Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells Zhonghua Wai Ke Za Zhi 44 2006 458 462
10. Z.W. Zhu, H. Friess, and L. Wang Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders Gut 48 2001 558 564
11. N. Akutsu, H. Yamamoto, and S. Sasaki Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma World J Gastroenterol 16 2010 3521 3528
12. H. Kim, G.L. Xu, and A.C. Borczuk The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor Am J Respir Cell Mol Biol 29 2003 694 701
13. S.S. Murthy, T. Shen, and A. De Rienzo Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma Oncogene 19 2000 410 416
14. Y.Y. Xiang, V. Ladeda, and J. Filmus Glypican-3 expression is silenced in human breast cancer Oncogene 20 2001 7408 7412
15. T. Nakatsura, Y. Yoshitake, and S. Senju Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker Biochem Biophys Res Commun 306 2003 16 25
16. H. Liu, P. Li, and Y. Zhai Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma World J Gastroenterol 16 2010 4410 4415
17. L. Libbrecht, T. Severi, and D. Cassiman Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules Am J Surg Pathol 30 2006 1405 1411
18. D. Kandil, G. Leiman, and M. Allegretta Glypican-3 immunocytochemistry in liver fine-needle aspirates: a novel stain to assist in the differentiation of benign and malignant liver lesions Cancer 111 2007 316 322
19. S. Kakar, A.M. Gown, and Z.D. Goodman Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms Arch Pathol Lab Med 131 2007 1648 1654
20. W.M. Coston, S. Loera, and S.K. Lau Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry Am J Surg Pathol 32 2008 433 444
21. S. Ligato, D. Mandich, and R.W. Cartun Utility of glypican-3 in differentiating hepatocellular carcinoma from other primary and metastatic lesions in FNA of the liver: an immunocytochemical study Mod Pathol 21 2008 626 631
22. N. Shafizadeh, L.D. Ferrell, and S. Kakar Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum Mod Pathol 21 2008 1011 1018
23. H. Shirakawa, T. Kuronuma, and Y. Nishimura Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer Int J Oncol 34 2009 649 656
24. H.L. Wang, F. Anatelli, and Q.J. Zhai Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions Arch Pathol Lab Med 132 2008 1723 1728
25. F.H. Wang, Y.C. Yip, and M. Zhang Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy J Clin Pathol 63 2010 599 603
26. K. Yorita, N. Takahashi, and H. Takai Prognostic significance of circumferential cell surface immunoreactivity of glypican-3 in hepatocellular carcinoma Liver Int 31 2010 120 131
27. N. Yamauchi, A. Watanabe, and M. Hishinuma The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma Mod Pathol 18 2005 1591 1598
28. L. Di Tommaso, G. Franchi, and Y.N. Park Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis Hepatology 45 2007 725 734
29. F. Anatelli, S.T. Chuang, and X.J. Yang Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy Am J Clin Pathol 130 2008 219 223
30. X.Y. Wang, F. Degos, and S. Dubois Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas Hum Pathol 37 2006 1435 1441
31. A. Nassar, C. Cohen, and M.T. Siddiqui Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies Diagn Cytopathol 37 2009 629 635
32. M. Capurro, I.R. Wanless, and M. Sherman Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma Gastroenterology 125 2003 89 97
33. D. Baumhoer, L. Tornillo, and S. Stadlmann Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples Am J Clin Pathol 129 2008 899 906
34. S. Ota, M. Hishinuma, and N. Yamauchi Oncofetal protein glypican-3 in testicular germ-cell tumor Virchows Arch 449 2006 308 314
35. D.L. Zynger, J.C. McCallum, and C. Luan Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns Histopathology 56 2010 750 757
36. D.L. Zynger, M.J. Everton, and N.D. Dimov Expression of glypican 3 in ovarian and extragonadal germ cell tumors Am J Clin Pathol 130 2008 224 230
37. G.E. Esheba, L.L. Pate, and T.A. Longacre Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary Am J Surg Pathol 32 2008 600 607
38. T. Nakatsura, T. Kageshita, and S. Ito Identification of glypican-3 as a novel tumor marker for melanoma Clin Cancer Res 10 2004 6612 6621
39. S. Stadlmann, U. Gueth, and D. Baumhoer Glypican-3 expression in primary and recurrent ovarian carcinomas Int J Gynecol Pathol 26 2007 341 344
40. S. Aviel-Ronen, S.K. Lau, and M. Pintilie Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma Mod Pathol 21 2008 817 825
41. H. He, W. Fang, and X. Liu Frequent expression of glypican-3 in Merkel cell carcinoma: an immunohistochemical study of 55 cases Appl Immunohistochem Mol Morphol 17 2009 40 46
42. K. Okon Glypican-3 is expressed in chromophobe renal cell carcinomas Pol J Pathol 59 2008 15 20
43. K.G. Ishak, Z. Goodman, and J.T. Stocker Metastatic tumors K.G. Ishak, Z. Goodman, J.T. Stocker, Tumors of the liver and intrahepatic bile ducts 2001 Armed Forces Institute Of, Pathology Washington, DC 343
44. J.W. Pickren, Y. Tsukada, and W.W. Lane Liver metastasis: analysis of autopsy data L.G.H. Weiss, H.A. Gilbert, Liver metastasis 1982 GK Hall and company Boston, MA 2 18
45. H. Shirakawa, H. Suzuki, and M. Shimomura Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma Cancer Sci 100 2009 1403 1407
46. T. Umezu, K. Shibata, and M. Shimaoka Gene silencing of glypican-3 in clear cell carcinoma of the ovary renders it more sensitive to the apoptotic agent paclitaxel in vitro and in vivo Cancer Sci 101 2010 143 148
47. S. Khan, M. Blackburn, and D.L. Mao Glypican-3 (GPC3) expression in human placenta: localization to the differentiated syncytiotrophoblast Histol Histopathol 16 2001 71 78
48. B. Liu, S. Paranjpe, and W.C. Bowen Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation Am J Pathol 175 2009 717 724
49. L. Pantanowitz, and C.N. Otis Glypican-3 immunohistochemistry in the ovary Histopathology 53 2008 115 117
50. T. Ushiku, H. Uozaki, and A. Shinozaki Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomas Cancer Sci 100 2009 626 632
51. B.V. Iglesias, G. Centeno, and H. Pascuccelli Expression pattern of glypican-3 (GPC3) during human embryonic and fetal development Histol Histopathol 23 2008 1333 1340
52. H.S. Cho, J.M. Ahn, and H.J. Han Glypican 3 binds to GLUT1 and decreases glucose transport activity in hepatocellular carcinoma cells J Cell Biochem 111 2010 1252 1259
53. M.I. Capurro, Y.Y. Xiang, and C. Lobe Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling Cancer Res 65 2005 6245 6254
54. M.I. Capurro, W. Shi, and S. Sandal Processing by convertases is not required for glypican-3-induced stimulation of hepatocellular carcinoma growth J Biol Chem 280 2005 41201 41206
55. S.I. Zittermann, M.I. Capurro, and W. Shi Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo Int J Cancer 126 2010 1291 1301
56. J.H. Luo, B. Ren, and S. Keryanov Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas Hepatology 44 2006 1012 1024
57. D. Maeda, S. Ota, and Y. Takazawa Glypican-3 expression in clear cell adenocarcinoma of the ovary Mod Pathol 22 2009 824 832
58. R.J. Ou-Yang, P. Hui, and X.J. Yang Expression of glypican 3 in placental site trophoblastic tumor Diagn Pathol 5 2010 64
59. K. Yamanaka, Y. Ito, and N. Okuyama Immunohistochemical study of glypican 3 in thyroid cancer Oncology 73 2007 389 394
60. S. Nemolato, D. Fanni, and A.G. Naccarato Lymphoepitelioma-like hepatocellular carcinoma: a case report and a review of the literature World J Gastroenterol 14 2008 4694 4696